In 2020, the World Health Organization (WHO) set out to achieve Cervical Cancer Elimination by 2030. While countries across the globe are making progress towards the WHO 90-70-90 targets for vaccination, screening, and treatment, more must be done to meet these important milestones. Cervical Cancer is the 4th most common form of cancer among women worldwide with an estimated 604,000 new cases and 342,000 deaths in 2020. Thanks to innovation, we know that effective primary and secondary interventions at different stages of life have saved countless women. The WHO 90-70-90 targets provide countries with an effective, evidence-based model to look towards to eliminate this disease once and for all. In order to support countries towards this goal, diverse, multi-stakeholder partnerships at the local, regional, and global level are imperative to achieve success. This session will highlight the importance of innovation in driving progress towards the WHO’s elimination targets, and how partnerships between industry and other multi-sectoral partners working towards achieving cervical cancer elimination has helped accelerate progress towards these targets. Some of these initiatives include but are not limited to the Global HPV Consortium, The American Cancer Society's Mission: HPV Cancer Free, and other partnerships dedicated towards ensuring a world free of cervical cancer.